Company Overview
About Artera
ArteraAI is a personalized precision medicine company based in the United States that develops AI-powered cancer therapy solutions. The company's multimodal AI test provides individualized results to enable personalized treatment decision-making between clinicians and patients. ArteraAI's prostate cancer test is included in the NCCN Guidelines and has an established CMS payment rate.
More Companies in California
Browse all companies in California →
Frequently Asked Questions about Artera
Categories
Technologies Used
Social Profiles
Key Decision Makers
Sydney Melnick Clinical Strategic Partnerships